Table 2.
t-IV Bu/Flu + rituximab | t-IV Bu/Flu | p value | |
---|---|---|---|
Day 30 (CD3) | 100% (10–100%) | 93% (75–100%) | 0.9 |
Day 30 (CD33) | 100% (79–100%) | 100% (61–100%) | 0.86 |
Day 30 (unsorted BM) | 98% (84–100%) | 98% (45–100%) | 0.54 |
Day 90 (CD3) | 94% (73–100%) | 90% (62–100%) | 0.25 |
Day 90 (CD33) | 100% | 100% (90–100%) | 0.35 |
Day 90 (unsorted BM) | 95% (88–100%) | 98% (93–100%) | 0.25 |